Literature DB >> 21888569

The role of tumor necrosis factor-alpha and other cytokines in depression: what dermatologists should know.

Swati Kannan1, Misha M Heller, Eric S Lee, John Ym Koo.   

Abstract

Recent studies have suggested that inflammatory responses may play an important role in the pathophysiology of depression. In fact, depressed individuals have been found to have higher levels of pro-inflammatory cytokines, especially tumor necrosis factor-alpha (TNF-α) and interleukin-6. This appears to be independent of any pre-existing chronic inflammatory disorders. In this article, various studies correlating increased levels of cytokines to depression are reviewed. As much as 60% of individuals with psoriasis also suffer from clinical depression. TNF-α antagonists, frequently used in the treatment of psoriasis, may be helpful in directly reducing depressive symptoms for patients with psoriasis and other chronic inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21888569     DOI: 10.3109/09546634.2011.619159

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  9 in total

Review 1.  [Comorbidities and psoriasis. Impact on clinical practice].

Authors:  S Gerdes; U Mrowietz
Journal:  Hautarzt       Date:  2012-03       Impact factor: 0.751

Review 2.  Psoriasis and Associated Psychiatric Disorders: A Systematic Review on Etiopathogenesis and Clinical Correlation.

Authors:  Bárbara Isabel Roque Cunha Ferreira; José Luís Pio Da Costa Abreu; José Pedro Gaspar Dos Reis; Américo Manuel Da Costa Figueiredo
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

Review 3.  Association Between Psoriasis and Depression: A Traditional Review.

Authors:  Faryal Mustansir Sahi; Ayesha Masood; Nuaman A Danawar; Andrew Mekaiel; Bilal Haider Malik
Journal:  Cureus       Date:  2020-08-13

Review 4.  Assessing and Improving Psychological Well-Being in Psoriasis: Considerations for the Clinician.

Authors:  Brittany Blackstone; Radhika Patel; Anthony Bewley
Journal:  Psoriasis (Auckl)       Date:  2022-03-25

Review 5.  Stress-Related Immune Markers in Depression: Implications for Treatment.

Authors:  Martina M Hughes; Thomas J Connor; Andrew Harkin
Journal:  Int J Neuropsychopharmacol       Date:  2016-01-16       Impact factor: 5.176

6.  Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients.

Authors:  Marthe-Lisa Schaarschmidt; Christian Kromer; Raphael Herr; Astrid Schmieder; Diana Sonntag; Sergij Goerdt; Wiebke K Peitsch
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

Review 7.  The efficacy of psychological interventions on psoriasis treatment: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Yi Xiao; Xingyu Zhang; Dan Luo; Yehong Kuang; Wu Zhu; Xiang Chen; Minxue Shen
Journal:  Psychol Res Behav Manag       Date:  2019-02-07

Review 8.  The Brain-Skin Axis in Psoriasis-Psychological, Psychiatric, Hormonal, and Dermatological Aspects.

Authors:  Luiza Marek-Jozefowicz; Rafał Czajkowski; Alina Borkowska; Bogusław Nedoszytko; Michał A Żmijewski; Wiesław J Cubała; Andrzej T Slominski
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923

Review 9.  Neuro-dermatological association between psoriasis and depression: an immune-mediated inflammatory process validating skin-brain axis theory.

Authors:  Shahzaib Maqbool; Arham Ihtesham; Muhammad Nadeem Langove; Sara Jamal; Tabdar Jamal; Hafiz Abu Safian
Journal:  AIMS Neurosci       Date:  2021-03-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.